Tau Medical Australia Pty Ltd — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
CAROL NSCLC treatment DeviceThis study aims to evaluate the safety of the CAROL device for treating lung tumors in patients diagnosed with non-small cell lung cancer (NSCLC) with tumor size ≤ 2 cm (cT1b). The primary objective is to assess safety by monitoring and grading adverse events using the CTCAE v5.0 criteria at one month following the procedure.	Cancer	Non applicable	À vérifier	Australia	À vérifier
CAROL NSCLC treatment DeviceThis study aims to evaluate the safety of the CAROL device for treating lung tumors in patients diagnosed with non-small cell lung cancer (NSCLC) with tumor size ≤ 2 cm (cT1b). The primary objective is to assess safety by monitoring and grading adverse events using the CTCAE v5.0 criteria at one month following the procedure.	Cancer	Non applicable	À vérifier	Australia	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
CAROL NSCLC treatment Device	Cancer	Non applicable	NCT07122258	Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.